Computational and Systems Immunology
Group leader
Our research focuses on developing novel computational and experimental strategies for designing next-generation therapeutics, diagnostics and vaccines by combining high-throughput single-cell antibody and T-cell receptor sequencing with artificial machine learning and high-dimensional statistics. Our ultimate aim is to improve public health by decreasing the burden of infectious and autoimmune diseases and cancer.